These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 10516348

  • 1. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [Abstract] [Full Text] [Related]

  • 2. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
    Lee YK, Kwon YJ, Yoon JW, Oh KS, Cha DR, Cho WY, Huh K, Pyo HJ, Kim HK.
    J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
    Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE.
    Arch Intern Med; 2000 Apr 10; 160(7):961-4. PubMed ID: 10761961
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Lalouschek W, Aull S, Deecke L, Schnider P, Uhl F, Zeiler K.
    Fortschr Neurol Psychiatr; 1996 Jul 10; 64(7):271-7. PubMed ID: 8765893
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
    Malinow MR.
    Can J Cardiol; 1999 Apr 10; 15 Suppl B():31B-34B. PubMed ID: 10350683
    [Abstract] [Full Text] [Related]

  • 15. Oral folate reduces plasma homocyst(e)ine levels in hemodialysis patients with cardiovascular disease.
    Stanford JL, Molina H, Phillips J, Kohlman-Trigoboff D, Moore J, Smith BM.
    Cardiovasc Surg; 2000 Dec 10; 8(7):567-71. PubMed ID: 11068219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC, Stanger O.
    Curr Drug Metab; 2005 Feb 10; 6(1):3-14. PubMed ID: 15720202
    [Abstract] [Full Text] [Related]

  • 20. Hyperhomocystinemia and the prevalence of symptomatic atherosclerotic vascular disease in Taiwanese chronic hemodialysis patients: a retrospective study.
    Chuang FR, Fang JT, Chen JB, Lin CL, Chen HY, Lee CN, Wang PH, Lee CH.
    Ren Fail; 2003 Sep 10; 25(5):765-74. PubMed ID: 14575285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.